Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / EDIT - Baisong Mei joins Editas Medicine as Chief Medical Officer

EDIT - Baisong Mei joins Editas Medicine as Chief Medical Officer

Editas Medicine Inc.
  • Baisong Mei has joined genome editing company Editas Medicine ( NASDAQ: EDIT ) in the role SVP and Chief Medical Officer, effective immediately.
  • Dr. Mei has over 20 years of experience in the biotech and pharmaceutical industry, serving as Senior Global Project Head in Rare Disease and Rare Blood Disorders at Sanofi ( SNY ) most recently.
  • He will lead clinical research and drug development for Editas' ( EDIT ) pipeline of experimental medicines across all therapeutic indications, including hematology, oncology, and ophthalmology.

For further details see:

Baisong Mei joins Editas Medicine as Chief Medical Officer
Stock Information
Company Name: Editas Medicine Inc.
Stock Symbol: EDIT
Market: NASDAQ
Website: editasmedicine.com
Menu
EDIT EDIT Quote EDIT Short EDIT News EDIT Articles EDIT Message Board
Get EDIT Alerts

News, Short Squeeze, Breakout and More Instantly...